⌘K

Login Start Free

Home/Filings/4/0001209191-17-049957

4//SEC Filing

Zorn Peter A 4

Accession 0001209191-17-049957

CIK 0001322505other

View on SEC.gov Company Profile

Filed

Aug 22, 8:00 PM ET

Accepted

Aug 23, 4:41 PM ET

Size

5.5 KB

Accession

0001209191-17-049957

Insider Transaction Report

Form 4

Period: 2017-08-21

ALBIREO PHARMA, INC.ALBO

Senior VP, Corp Dev, GC & Sec

Transactions

Award
Stock Option (right to buy)
2017-08-21+13,000→ 13,000 total
Exercise: $24.48Exp: 2027-08-20→ Common Stock (13,000 underlying)

Footnotes (1)

[F1]This option will vest and become exercisable in equal installments on the last day of 16 consecutive calendar quarters beginning with September 30, 2017 and ending on June 30, 2021.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

ALBIREO PHARMA, INC.

CIK 0001322505

Entity typeother

Related Parties

1

filerCIK 0001357865

Filing Metadata

Form type: 4
Filed: Aug 22, 8:00 PM ET
Accepted: Aug 23, 4:41 PM ET
Size: 5.5 KB

View on SEC.gov